These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12716757)

  • 1. Downregulation of fibronectin overexpression reduces basement membrane thickening and vascular lesions in retinas of galactose-fed rats.
    Roy S; Sato T; Paryani G; Kao R
    Diabetes; 2003 May; 52(5):1229-34. PubMed ID: 12716757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin receptor blockade prevents augmented extracellular matrix component mRNA expression and capillary basement membrane thickening in the retina of diabetic and galactose-fed rats.
    Evans T; Deng DX; Chen S; Chakrabarti S
    Diabetes; 2000 Apr; 49(4):662-6. PubMed ID: 10871206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early biosynthetic changes in the diabetic-like retinopathy of galactose-fed rats.
    Roy S; Lorenzi M
    Diabetologia; 1996 Jun; 39(6):735-8. PubMed ID: 8781771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A long-term siRNA strategy regulates fibronectin overexpression and improves vascular lesions in retinas of diabetic rats.
    Roy S; Nasser S; Yee M; Graves DT; Roy S
    Mol Vis; 2011; 17():3166-74. PubMed ID: 22171163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tight glycemic control regulates fibronectin expression and basement membrane thickening in retinal and glomerular capillaries of diabetic rats.
    Cherian S; Roy S; Pinheiro A; Roy S
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):943-9. PubMed ID: 18775856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galactose-induced retinal microangiopathy in rats.
    Kern TS; Engerman RL
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):490-6. PubMed ID: 7843917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of retinal lesions in alloxan-diabetic rats and galactose-fed rats.
    Kern TS; Engerman RL
    Curr Eye Res; 1994 Dec; 13(12):863-7. PubMed ID: 7720392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-peptide and retinal microangiopathy in diabetes.
    Chakrabarti S; Khan ZA; Cukiernik M; Zhang W; Sima AA
    Exp Diabesity Res; 2004; 5(1):91-6. PubMed ID: 15198374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increases in collagen type IV and laminin in galactose-induced retinal capillary basement membrane thickening--prevention by an aldose reductase inhibitor.
    Das A; Frank RN; Zhang NL; Samadani E
    Exp Eye Res; 1990 Mar; 50(3):269-80. PubMed ID: 2108050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal capillary dilation: early diabetic-like retinopathy in the galactose-fed rat model.
    Glover JP; Jacot JL; Basso MD; Hohman TC; Robison WG
    J Ocul Pharmacol Ther; 2000 Apr; 16(2):167-72. PubMed ID: 10803427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of combined antisense oligonucleotides against high-glucose- and diabetes-induced overexpression of extracellular matrix components and increased vascular permeability.
    Oshitari T; Polewski P; Chadda M; Li AF; Sato T; Roy S
    Diabetes; 2006 Jan; 55(1):86-92. PubMed ID: 16380480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinal capillaries: basement membrane thickening by galactosemia prevented with aldose reductase inhibitor.
    Robison WG; Kador PF; Kinoshita JH
    Science; 1983 Sep; 221(4616):1177-9. PubMed ID: 6612330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased lysyl oxidase level protects against development of retinal vascular lesions in diabetic retinopathy.
    Kim D; Mecham RP; Nguyen NH; Roy S
    Exp Eye Res; 2019 Jul; 184():221-226. PubMed ID: 31022398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-dependent retinal capillary pericyte degeneration in galactose-fed dogs.
    Kador PF; Takahashi Y; Akagi Y; Blessing K; Randazzo J; Wyman M
    J Ocul Pharmacol Ther; 2007 Feb; 23(1):63-9. PubMed ID: 17341153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary myo-inositol supplementation does not prevent retinal and glomerular vascular structural changes in chronically diabetic rats.
    Tilton RG; Faller AM; LaRose LS; Burgan J; Williamson JR
    J Diabetes Complications; 1993; 7(3):188-98. PubMed ID: 8343613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sorbinil prevention of diabetic-like retinopathy in the galactose-fed rat model.
    Robison WG; Laver NM; Jacot JL; Glover JP
    Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2368-80. PubMed ID: 7591626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic-like retinopathy: early and late intervention therapies in galactose-fed rats.
    Robison WG; Jacot JL; Glover JP; Basso MD; Hohman TC
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1933-41. PubMed ID: 9727416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Diabetes-Induced Lysyl Oxidase Overexpression Prevents Retinal Vascular Lesions Associated With Diabetic Retinopathy.
    Song B; Kim D; Nguyen NH; Roy S
    Invest Ophthalmol Vis Sci; 2018 Dec; 59(15):5965-5972. PubMed ID: 30550614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldose reductase and retinal capillary basement membrane thickening.
    Robison WG; Nagata M; Kinoshita JH
    Exp Eye Res; 1988 Mar; 46(3):343-8. PubMed ID: 3127228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor.
    Robison WG; Nagata M; Laver N; Hohman TC; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2285-92. PubMed ID: 2509395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.